Adipose Tissue Inflammation in Individuals Undergoing Bariatric Surgery
1 other identifier
observational
84
1 country
1
Brief Summary
A growing body of work done over the past few decades has established that adipose tissue as an active endocrine organ which secretes a wide range of metabolic and immunological factors collectively called "adipokines (1)." Importantly, these secreted factors enter into the circulation and have paracrine and autocrine actions, which profoundly impact systemic metabolism (e.g., insulin sensitivity). Additionally, in animals, loss of ovarian hormone production via ovariectomy (similar to menopause in humans) leads to increases in both in adipose tissue mass and in adipose tissue inflammation (2) making this tissue less healthy than that from premenopausal animals. To date, no studies have investigated the effect of menopause on abdominal fat in overweight individuals. Knowing if adipose tissue-specific changes occur with menopause may potentially lead to recommendations or therapeutics to improve women's health post menopause.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2017
CompletedFirst Submitted
Initial submission to the registry
January 20, 2018
CompletedFirst Posted
Study publicly available on registry
February 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2019
CompletedOctober 3, 2019
October 1, 2019
1.7 years
January 20, 2018
October 1, 2019
Conditions
Outcome Measures
Primary Outcomes (3)
TNFa
TNFa
measured in the one sample collected at surgery
Il-6
Il-6
measured in the one sample collected at surgery
macrophage
macrophage
measured in the one sample collected at surgery
Interventions
We are recruiting only those going through bariatric surgery
Eligibility Criteria
All subject are already scheduled to have bariatric surgery at the University of Missouri-Columbia Department of Surgery.
You may qualify if:
- Women who are premenopausal or who are postmenopausal and have been for at least one year.
- Males will be recruited to age match female subjects. All subject are already scheduled to have bariatric surgery at the University of Missouri-Columbia Department of Surgery.
You may not qualify if:
- Women who are perimenopausal. Women who are on Hormone Replacement Therapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Missouri
Columbia, Missouri, 65211, United States
Related Publications (1)
Porter JW, Barnas JL, Welly R, Spencer N, Pitt J, Vieira-Potter VJ, Kanaley JA. Age, Sex, and Depot-Specific Differences in Adipose-Tissue Estrogen Receptors in Individuals with Obesity. Obesity (Silver Spring). 2020 Sep;28(9):1698-1707. doi: 10.1002/oby.22888. Epub 2020 Jul 31.
PMID: 32734695DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jill Kanaley, PhD
University of Missouri-Columbia
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor
Study Record Dates
First Submitted
January 20, 2018
First Posted
February 1, 2018
Study Start
July 1, 2017
Primary Completion
March 31, 2019
Study Completion
July 1, 2019
Last Updated
October 3, 2019
Record last verified: 2019-10
Data Sharing
- IPD Sharing
- Will not share